Health ❯ Healthcare ❯ Pharmaceuticals ❯ Medications

GLP-1 Drugs

Canada Expands Access to Semaglutide With Home Delivery and First G7 Generics

U.S. patients face years-long waits for approved generics due to extended Novo Nordisk patents.

Yahoo Finance Highlights Merck and Bristol Myers as Value Plays Outside the GLP-1 Surge

White House Clinches GLP-1 Price Deal as Lilly Sets Zepbound and Pill Pricing

GLP-1 Drugs Tied to Atypical PET-CT Uptake, Raising Misdiagnosis Risk

UK Regulator Probes Pancreatitis Cases Tied to GLP-1 Weight-Loss Therapies

NHS Expands Mounjaro Prescriptions to Highest-Risk Patients as Safety Warnings Grow

MHRA Warns Women on Ozempic, Mounjaro and Wegovy to Use Effective Contraception After Pregnancy Reports

Eli Lilly's Oral GLP-1 Pill Demonstrates Success in Phase 3 Trials

FDA Declares Semaglutide Shortage Over, Impacting Compounded Drug Market

Scams and Counterfeits Exploit Demand for Weight-Loss Drugs